Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

GE Healthcare™ Ficoll-Paque™ PREMIUM, 1.078g/mL Available on GSA/VA Contract for Federal Government customers only.

For density gradient centrifugation preparations of mononuclear cells from peripheral blood, bone marrow and umbilical cord blood. GE Healthcare Life Sciences™ Ficoll-Paque™ PREMIUM is a range of sterile, ready-to-use density gradient media manufactured under a Quality Management System.

Manufacturer:  GE Healthcare™ 17544203

 View more versions of this product

Catalog No. 45-001-752


  Check Availability
Add to cart

Specifications

Description

  • Manufactured under a Quality Management certified to ISO13485:2003
  • Sterile and ready-to-use; stable for at least 3 years when stored correctly
  • Low levels of endotoxin (<0.12 EU/mL) secured and tested
  • Ficoll-Paque PREMIUM
  • Optimized for the isolation of mononuclear cells from human peripheral blood, bone marrow, and umbilical cord blood.
  • Ficoll-Paque PREMIUM 1.084
  • Can be used for isolating a broad range of human mononuclear cells including those of a higher density and for separating blood cells from mice or rats.
  • Ficoll-Paque PREMIUM 1.073
  • Can be used when isolating lower-density human mononuclear cells (e.g., mesenchymal stromal cells or monocytes).
Description & Specifications

Specifications

6 x 500mL
For the isolation of mononuclear cells from human peripheral blood, bone marrow and umbilical cord blood
<0.12EU/mL
Colorless to Slightly Yellow
4° to 30°C
1.078g/mL
Liquid
Yes
Centrifugation Media
1.078g/mL

Safety and Handling

ShelfLife : 3 years

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit